Sanofi SA
PAR:SAN

Watchlist Manager
Sanofi SA Logo
Sanofi SA
PAR:SAN
Watchlist
Price: 93.17 EUR 2.53% Market Closed
Market Cap: 116.8B EUR
Have any thoughts about
Sanofi SA?
Write Note

Relative Value

The Relative Value of one SAN stock under the Base Case scenario is 130.98 EUR. Compared to the current market price of 93.17 EUR, Sanofi SA is Undervalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SAN Relative Value
Base Case
130.98 EUR
Undervaluation 29%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
58
Median 3Y
2.6
Median 5Y
2.6
Industry
2.5
Forward
2.5
vs History
57
vs Industry
33
Median 3Y
17.6
Median 5Y
17.6
Industry
21.9
Forward
12.1
vs History
7
vs Industry
33
Median 3Y
11.4
Median 5Y
12
Industry
16.5
vs History
77
vs Industry
16
Median 3Y
19.7
Median 5Y
20.6
Industry
23.6
vs History
60
vs Industry
47
Median 3Y
1.6
Median 5Y
1.6
Industry
2.1
vs History
98
vs Industry
55
Median 3Y
2.8
Median 5Y
2.8
Industry
2.6
Forward
2.6
vs History
98
vs Industry
65
Median 3Y
4
Median 5Y
4.1
Industry
5.2
vs History
98
vs Industry
43
Median 3Y
8.7
Median 5Y
8.6
Industry
13.3
Forward
8.9
vs History
98
vs Industry
40
Median 3Y
12.7
Median 5Y
13.2
Industry
16.6
Forward
10.8
vs History
12
vs Industry
32
Median 3Y
12.3
Median 5Y
12.8
Industry
15.6
vs History
7
vs Industry
22
Median 3Y
16.2
Median 5Y
16.7
Industry
19.1
vs History
87
vs Industry
50
Median 3Y
1.1
Median 5Y
1.1
Industry
1.9

Multiples Across Competitors

SAN Competitors Multiples
Sanofi SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Sanofi SA
PAR:SAN
116.6B EUR 1.9 16.6 6.7 8.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
FR
Sanofi SA
PAR:SAN
Average P/E: 30.4
16.6
121%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top